MediciNova Inc (MNOV)
2.13
+0.13
(+6.50%)
USD |
NASDAQ |
Nov 22, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
MediciNova Free Cash Flow: -8.553M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -8.553M |
March 31, 2024 | -8.143M |
December 31, 2023 | -7.452M |
September 30, 2023 | -10.96M |
June 30, 2023 | -12.31M |
March 31, 2023 | -12.36M |
December 31, 2022 | -12.91M |
September 30, 2022 | -12.54M |
June 30, 2022 | -12.84M |
March 31, 2022 | -9.285M |
December 31, 2021 | -9.410M |
September 30, 2021 | -7.753M |
June 30, 2021 | -8.644M |
March 31, 2021 | -11.84M |
December 31, 2020 | -10.86M |
September 30, 2020 | -11.29M |
June 30, 2020 | -9.422M |
March 31, 2020 | -8.986M |
December 31, 2019 | -9.136M |
September 30, 2019 | -8.368M |
June 30, 2019 | -8.065M |
March 31, 2019 | -8.066M |
December 31, 2018 | -9.124M |
September 30, 2018 | -8.526M |
June 30, 2018 | -8.710M |
Date | Value |
---|---|
March 31, 2018 | -8.467M |
December 31, 2017 | -6.924M |
September 30, 2017 | -6.954M |
June 30, 2017 | -6.651M |
March 31, 2017 | -6.737M |
December 31, 2016 | -6.631M |
September 30, 2016 | -7.071M |
June 30, 2016 | -6.627M |
March 31, 2016 | -6.362M |
December 31, 2015 | -7.155M |
September 30, 2015 | -6.671M |
June 30, 2015 | -7.090M |
March 31, 2015 | -7.185M |
December 31, 2014 | 0.813M |
September 30, 2014 | -2.188M |
June 30, 2014 | -2.488M |
March 31, 2014 | -3.301M |
December 31, 2013 | -10.69M |
September 30, 2013 | -8.841M |
June 30, 2013 | -9.391M |
March 31, 2013 | -11.13M |
December 31, 2012 | -11.95M |
September 30, 2012 | -10.71M |
June 30, 2012 | -11.24M |
March 31, 2012 | -12.78M |
Free Cash Flow Range, Past 5 Years
-12.91M
Minimum
Dec 2022
-7.452M
Maximum
Dec 2023
-10.25M
Average
-9.422M
Median
Jun 2020
Free Cash Flow Benchmarks
BioVie Inc | -19.35M |
BridgeBio Pharma Inc | -456.32M |
Ikena Oncology Inc | -61.56M |
NovaBay Pharmaceuticals Inc | -4.812M |
Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -2.811M |
Cash from Investing (Quarterly) | -0.0009M |
Free Cash Flow Per Share (Quarterly) | -0.0573 |
Free Cash Flow Yield | -8.19% |